Skip to content

ROG SIX

Roche

Description

ROG · SIX

F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.

Wikipedia · CC BY-SA 4.0

Headquarters
CH
Website
Website

Structure of Roche

Roche

Company

4 connections
PeersCompetition and partners
OwnershipInvestment and holdings
Relationship began2026
RocheCompany · 4 connections
Layer 1

PeersCompetition and partners2

OwnershipInvestment and holdings2

Relations

Arrows show the direction of the relationship. Filter to focus on a business area.

  • Rocheowns →Genentech
    Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-10-07 13:00
      Genentech in the United States is a fully owned subsidiary in the Roche Group.
      View source
  • Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-10-07 13:00
      Roche is the majority shareholder in Chugai Pharmaceutical, a major innovator in the Japanese therapeutic antibody market.
      View source
    • CompanyPR Newswire news releases2026-10-07 13:00
      Roche is the majority shareholder in Chugai Pharmaceutical
      View source
  • Rochesupplies →tests
    Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-10-07 13:00
      *Research Use Only* tests is complete, Roche anticipates deploying additional instruments and expediting delivery of more tests to support the response.
      View source
  • Innoventpartners with →Roche
    Fact90%
    View evidence
    • CompanyPR Newswire news releases2026-10-09
      Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.
      View source
  • Fact55%
    View evidence

Showing 1 to 5 of 5

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 1
partners withInnovent

Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.

PR Newswire news releases · 2026-10-09

View evidence
  • CompanyPR Newswire news releases2026-10-09
    Innovent has entered into more than 30 strategic partnerships with global players such as Eli Lilly, Roche, Takeda, Pfizer, Sanofi, Incyte, and MD Anderson Cancer Center, representing an aggregate value of over RMB 350 billion.
    View source
FactEvidence 1

Genentech in the United States is a fully owned subsidiary in the Roche Group.

PR Newswire news releases · 2026-10-07 13:00

View evidence
  • CompanyPR Newswire news releases2026-10-07 13:00
    Genentech in the United States is a fully owned subsidiary in the Roche Group.
    View source
FactEvidence 2

Roche is the majority shareholder in Chugai Pharmaceutical, a major innovator in the Japanese therapeutic antibody market.

PR Newswire news releases · 2026-10-07 13:00

View evidence
  • CompanyPR Newswire news releases2026-10-07 13:00
    Roche is the majority shareholder in Chugai Pharmaceutical, a major innovator in the Japanese therapeutic antibody market.
    View source
  • CompanyPR Newswire news releases2026-10-07 13:00
    Roche is the majority shareholder in Chugai Pharmaceutical
    View source
FactEvidence 1
year founded1,896 year

Roche was founded in Basel, Switzerland in 1896

PR Newswire news releases · 2026-10-07 13:00

View evidence
  • CompanyPR Newswire news releases2026-10-07 13:00
    Roche was founded in Basel, Switzerland in 1896
    View source
FactEvidence 1
suppliestests

*Research Use Only* tests is complete, Roche anticipates deploying additional instruments and expediting delivery of more tests to support the response.

PR Newswire news releases · 2026-10-07 13:00

View evidence
  • CompanyPR Newswire news releases2026-10-07 13:00
    *Research Use Only* tests is complete, Roche anticipates deploying additional instruments and expediting delivery of more tests to support the response.
    View source

Showing 1 to 6 of 6

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Not available: Company signals · Financials · Filings · Guidance